跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
蔡 佩珊
教授
,
護理學系
https://orcid.org/0000-0003-1274-574X
電子郵件
ptsai
tmu.edu
tw
h-index
5876
引文
39
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1993 …
2024
每年研究成果
概覽
指紋
網路
專案
(23)
研究成果
(227)
資料集
(7)
類似的個人檔案
(6)
指紋
查看啟用 Pei-Shan Tsai 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Nursing and Health Professions
Meta Analysis
86%
Systematic Review
64%
Confidence Interval
51%
Quality of Life
44%
Sleep Quality
40%
Psychometry
30%
Symptom
30%
Fibromyalgia
26%
Blood Pressure
25%
Effect Size
22%
Traumatic Brain Injury
21%
Self Care
20%
Cohort Analysis
18%
Depression
17%
Odds Ratio
17%
Ischemic Heart Disease
17%
Pittsburgh Sleep Quality Index
17%
Sleep Disorder
16%
Health Status
15%
Disease
15%
Malignant Neoplasm
15%
Medline
14%
Sleep Time
13%
Breast Cancer
13%
Heart Failure
13%
Auriculotherapy
13%
Biofeedback
13%
Prevalence
12%
Self-Efficacy
12%
Test Retest Reliability
12%
Internal Consistency
11%
Hospital
11%
Drug Therapy
11%
Logistic Regression Analysis
10%
Actimetry
9%
CINAHL
9%
Construct Validity
9%
Chronic Kidney Failure
9%
Systolic Blood Pressure
9%
Diabetes Mellitus
9%
Beck Depression Inventory
9%
Primary Insomnia
8%
Pain Assessment
8%
Prehypertension
8%
Hemodialysis
8%
Postoperative Pain
8%
Rehabilitation Engineering
8%
Urine Incontinence
8%
Network Meta-Analysis
8%
Health Care Utilization
8%
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide
100%
Nuclear Factor
43%
Endotoxin
40%
Nitric Oxide
34%
Amino Acid Transporter
32%
Inducible Nitric Oxide Synthase
32%
Alternative Complement Pathway C3 C5 Convertase
32%
Heme Oxygenase 1
31%
Magnesium Sulfate
30%
Acute Lung Injury
27%
Hemorrhagic Shock
27%
Cohort Study
22%
Dexmedetomidine
21%
Hemin
19%
Ischemia
18%
Inflammation
17%
Arginine
16%
Endotoxemia
16%
Sepsis
16%
Synthetase
15%
Antiinflammatory Activity
14%
Isoenzyme
13%
Prostaglandin E2
13%
Anti-Inflammation
13%
Zusanli
13%
Leg Ischemia
13%
Ketamine
13%
Phosphatidylinositol 3 Kinase
13%
Auriculotherapy
13%
Ischemic Heart Disease
13%
Calcium Channel L Type
12%
Randomized Controlled Trial
11%
Sodium Chloride
11%
Guanosine Triphosphate Cyclohydrolase I
11%
Mitogen Activated Protein Kinase
10%
Phosphotransferase
10%
Cytokine
10%
Bleeding
9%
Clonidine
8%
Testis Torsion
8%
Prothrombin
8%
Ventilator Induced Lung Injury
8%
Naloxone
8%
Transcription Factor AP 1
8%
Chronic Hepatitis C
8%
Lidocaine
8%
Pneumonia
8%
Interferon
8%
Liver Injury
6%
Malonaldehyde
6%
Medicine and Dentistry
Lipopolysaccharide
47%
Meta-Analysis
39%
Cohort Analysis
35%
Auriculotherapy
30%
Cesarean Section
30%
Randomized Controlled Trial
28%
Nitric Oxide
27%
Systematic Review
26%
Hemorrhagic Shock
26%
Ischemic Heart Disease
22%
Resuscitation
19%
General Anesthesia
18%
Symptom
16%
Nuclear Factor
15%
Blood Pressure
15%
Synthetase
13%
Breast Cancer
13%
Biofeedback
13%
Dexmedetomidine
13%
Fibromyalgia
13%
Zusanli
13%
Guanosine Triphosphate Cyclohydrolase I
13%
Inducible Nitric Oxide Synthase
10%
Amino Acid Transporter
10%
Odds Ratio
9%
Quality of Life
9%
Hazard Ratio
9%
Acute Lung Injury
9%
Magnesium Sulfate
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Lower Limb
9%
Hyperlipidemia
8%
Antiinflammatory Activity
8%
Ketamine
8%
L-Type Calcium Channel
8%
Apoplexy
8%
Postoperative Pain
8%
Prenatal Diagnosis
8%
Systolic Blood Pressure
8%
Rehabilitation Engineering
7%
Sodium Chloride
7%
Macrophage
7%
Cardiovascular Risk
7%
Self Concept
6%
Malignant Neoplasm
6%
Endotoxemia
6%
Arginine
6%
Fentanyl
6%
Blood Pressure Reduction
6%
Spinal Anaesthesia
6%
